CRON Q3 2024 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

Q3 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$34M+38.1% YoY

Gross Profit

$4M10.5% margin

Operating Income

-$34M-98.2% margin

Net Income

$8M24.4% margin

EPS (Diluted)

$0.02

QoQ Revenue Growth

+23.4%

Cash Flow

Operating Cash Flow

$12M

Free Cash Flow

$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$53M

Stockholders' Equity

$1.1B

Cash & Equivalents

$862M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$34M	$25M	+38.1%
Gross Profit	$4M	$4M	-9.0%
Operating Income	-$34M	-$22M	-54.6%
Net Income	$8M	-$2M	+607.8%